Schedule 13G ownership disclosure
Lakefront Biotherapeutics NV
Security class unavailable · CUSIP: B44170106
Event date: 2021-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,923,555
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001562230-21-000110
- Form type
- SC 13G
- Filer
- Capital International Investors
- CIK
- CIK 1562230
- Filed
- May 10, 2021
- Reporting period
- Apr 30, 2021
- Description
- Schedule 13G beneficial ownership